In this 1 year randomized trial of patients with moderate to severe COPD, those randomized to tiotropium had significantly fewer COPD exacerbations and overall hospitalizations than those randomized to salmeterol. For patients with moderate to severe COPD, tiotropium may be better than salmeterol in reducing exacerbations and hospitalizations (abstract)
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.